USFDA inspection at manufacturing facility of Marksans Pharma's subsidiary Time-Cap Laboratories, Inc.

Marksans Pharma Limited has announced that a current Good Manufacturing Practices (cGMP) inspection was conducted by the USFDA at the manufacturing facility of the Company's wholly owned subsidiary Time-Cap Laboratories, Inc. located at 7, Michael Avenue, Farmingdale, New York, USA ("the Subsidiary") from 16th April 2025 to 24th April 2025.

On conclusion of the inspection, the Subsidiary has received One (1) inspectional observation in Form 483. There is no data integrity observation. The Subsidiary will work closely with the USFDA and is committed to address the observation comprehensively within the stipulated time.

Shares of Marksans Pharma Limited was last trading in BSE at Rs. 216.00 as compared to the previous close of Rs. 228.30. The total number of shares traded during the day was 118135 in over 2104 trades.

The stock hit an intraday high of Rs. 234.95 and intraday low of 212.75. The net turnover during the day was Rs. 26038307.00.

Source : Equity Bulls

Keywords

MarksansPharma INE750C01026 TimeCapLaboratoriesInc USFDA Inspection ManufacturingFacility Farmingdale NewYork